Skaana Management »

Sarepta Therapeutics shares owned by Skaana Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Skaana Management from 13F filings

Historical chart of Skaana Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Skaana Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Skaana Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $482k 5.0k 96.43

More positions owned by Skaana Management

Tesla Note 2.000% 5/1 (Principal)
Centerpoint Energy Incconv Pfd Taxbl Equity
Occidental Petroleum Corporation Put Option (OXY)
RBC Bearings Incorporated Put Option (RBC)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Rbc Bearings 5% Cnv Pfd Sr A (RBCP)
Epr Pptys PFD C CV 5.75% (EPR.PC)
Carnival Corporation 144a 5.75 10/01/2024 Fixed Income (Principal)
United States Stl Corp Note 5.000%11/0 (Principal)
Colony Capital Operating Co 5.75 07/15/2025 Fixed Income (Principal)
Wts/california Resources Corp Exp10/23/2024 Warr (CRCQW)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Ncl Corp Note 6.000% 5/1 (Principal)
Rivian Automotive Inc 144a 4.625 03/15/2029 Fixed Income (Principal)
Algonquin Pwr Utils Corp Unit 06/15/2024 (AQNU)

View all positions for Skaana Management

Top funds holding Sarepta Therapeutics

Vanguard Group
Henderson Group
venBio Select Advisor
Wellington Management Company
Citadel Advisors
Bank of New York Mellon
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
Caption Management
Casdin Capital
Norges Bank Investment Management
EcoR1 Capital
Royal Bank of Canada
Millennium Management

View all funds holding Sarepta Therapeutics